Lo Russo et al. (2019) did not find significant differences in tumor-infiltrating T cells of the following types: CD4+/CD8+ lymphocytes, regulatory T cells (Tregs), peritumoral and stromal myeloperoxidase myeloid cells, and PD-1+ and PD-L1+ immune cells. This evidence concerns the gene MPO and neoplasm.